Cargando…

A Different Microbiome Gene Repertoire in the Airways of Cystic Fibrosis Patients with Severe Lung Disease

In recent years, next-generation sequencing (NGS) was employed to decipher the structure and composition of the microbiota of the airways in cystic fibrosis (CF) patients. However, little is still known about the overall gene functions harbored by the resident microbial populations and which specifi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bacci, Giovanni, Mengoni, Alessio, Fiscarelli, Ersilia, Segata, Nicola, Taccetti, Giovanni, Dolce, Daniela, Paganin, Patrizia, Morelli, Patrizia, Tuccio, Vanessa, De Alessandri, Alessandra, Lucidi, Vincenzina, Bevivino, Annamaria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578044/ https://www.ncbi.nlm.nih.gov/pubmed/28758937 http://dx.doi.org/10.3390/ijms18081654

Ejemplares similares

Changes in Cystic Fibrosis Airway Microbial Community Associated with a Severe Decline in Lung Function
por: Paganin, Patrizia, et al.
Publicado: (2015)

Untargeted Metagenomic Investigation of the Airway Microbiome of Cystic Fibrosis Patients with Moderate-Severe Lung Disease
por: Bacci, Giovanni, et al.
Publicado: (2020)

Pyrosequencing Unveils Cystic Fibrosis Lung Microbiome Differences Associated with a Severe Lung Function Decline
por: Bacci, Giovanni, et al.
Publicado: (2016)

Correction: Pyrosequencing Unveils Cystic Fibrosis Lung Microbiome Differences Associated with a Severe Lung Function Decline
por: Bacci, Giovanni, et al.
Publicado: (2016)

Lung and Gut Microbiota Changes Associated with Pseudomonas aeruginosa Infection in Mouse Models of Cystic Fibrosis
por: Bacci, Giovanni, et al.
Publicado: (2021)

Soil Bacterial Community Response to Differences in Agricultural Management along with Seasonal Changes in a Mediterranean Region
por: Bevivino, Annamaria, et al.
Publicado: (2014)

Methicillin-resistant Staphylococcus aureus eradication in cystic fibrosis patients: A randomized multicenter study
por: Dolce, Daniela, et al.
Publicado: (2019)

Comparison between Gibson–Cooke and Macroduct Methods in the Cystic Fibrosis Neonatal Screening Program and in Subjects Who Are Cystic Fibrosis Screen-Positive with an Inconclusive Diagnosis
por: Dolce, Daniela, et al.
Publicado: (2023)

An inflammatory Signature of Glucose Impairment in Cystic Fibrosis
por: Montemari, Anna Lisa, et al.
Publicado: (2022)

Environmental Microbial Contamination during Cystic Fibrosis Group-Based Psychotherapy
por: Rossitto, Martina, et al.
Publicado: (2021)

Clonal Diversity, Biofilm Formation, and Antimicrobial Resistance among Stenotrophomonas maltophilia Strains from Cystic Fibrosis and Non-Cystic Fibrosis Patients
por: Pompilio, Arianna, et al.
Publicado: (2020)

Serratiopeptidase Affects the Physiology of Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients
por: Artini, Marco, et al.
Publicado: (2022)

Essential oils against bacterial isolates from cystic fibrosis patients by means of antimicrobial and unsupervised machine learning approaches
por: Ragno, Rino, et al.
Publicado: (2020)

Anti-Virulence Properties of Coridothymus capitatus Essential Oil against Pseudomonas aeruginosa Clinical Isolates from Cystic Fibrosis Patients
por: Vrenna, Gianluca, et al.
Publicado: (2021)

Whole-genome epidemiology, characterisation, and phylogenetic reconstruction of Staphylococcus aureus strains in a paediatric hospital
por: Manara, Serena, et al.
Publicado: (2018)

Within-host microevolution of Pseudomonas aeruginosa in Italian cystic fibrosis patients
por: Marvig, Rasmus Lykke, et al.
Publicado: (2015)

Cooperative pathogenicity in cystic fibrosis: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in mixed biofilm
por: Pompilio, Arianna, et al.
Publicado: (2015)

Anti-Virulence Potential of a Chionodracine-Derived Peptide against Multidrug-Resistant Pseudomonas aeruginosa Clinical Isolates from Cystic Fibrosis Patients
por: Artini, Marco, et al.
Publicado: (2022)

Essential Oils Biofilm Modulation Activity and Machine Learning Analysis on Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients
por: Artini, Marco, et al.
Publicado: (2022)

Stenotrophomonas maltophilia Phenotypic and Genotypic Diversity during a 10-year Colonization in the Lungs of a Cystic Fibrosis Patient
por: Pompilio, Arianna, et al.
Publicado: (2016)

The Impact of Soil-Applied Biochars From Different Vegetal Feedstocks on Durum Wheat Plant Performance and Rhizospheric Bacterial Microbiota in Low Metal-Contaminated Soil
por: Latini, Arianna, et al.
Publicado: (2019)

Gut microbiota signatures in cystic fibrosis: Loss of host CFTR function drives the microbiota enterophenotype
por: Vernocchi, Pamela, et al.
Publicado: (2018)

Challenges and Promises for Planning Future Clinical Research Into Bacteriophage Therapy Against Pseudomonas aeruginosa in Cystic Fibrosis. An Argumentative Review
por: Rossitto, Martina, et al.
Publicado: (2018)

Cystic fibrosis in Tuscany: evolution of newborn screening strategies over time to the present
por: Botti, Matteo, et al.
Publicado: (2021)

Evolution of Stenotrophomonas maltophilia in Cystic Fibrosis Lung over Chronic Infection: A Genomic and Phenotypic Population Study
por: Esposito, Alfonso, et al.
Publicado: (2017)

Dornase alfa in Cystic Fibrosis: indications, comparative studies and effects on lung clearance index
por: Terlizzi, Vito, et al.
Publicado: (2022)

Phenotypic and genotypic characterization of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis: Genome diversity, biofilm formation, and virulence
por: Pompilio, Arianna, et al.
Publicado: (2011)

To the Land and Beyond: Crab Microbiomes as a Paradigm for the Evolution of Terrestrialization
por: Cannicci, Stefano, et al.
Publicado: (2020)

Hypertonic saline in people with cystic fibrosis: review of comparative studies and clinical practice
por: Terlizzi, Vito, et al.
Publicado: (2021)

Perspectives and Challenges in Microbial Communities Metabolic Modeling
por: Bosi, Emanuele, et al.
Publicado: (2017)

P163 Effects of the SARS-CoV-2 pandemic on attendance at the cystic fibrosis centre and the definition of the microbiological status of cystic fibrosis patients in Tuscany
por: Dolce, D., et al.
Publicado: (2021)

Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients
por: Pompilio, Arianna, et al.
Publicado: (2010)

In Vitro Newly Isolated Environmental Phage Activity against Biofilms Preformed by Pseudomonas aeruginosa from Patients with Cystic Fibrosis
por: Fiscarelli, Ersilia Vita, et al.
Publicado: (2021)

G378X‐I148T CFTR variant: A new complex allele in a cystic fibrosis newborn with pancreatic insufficiency
por: Terlizzi, Vito, et al.
Publicado: (2022)

Anti-Virulence Activity of the Cell-Free Supernatant of the Antarctic Bacterium Psychrobacter sp. TAE2020 against Pseudomonas aeruginosa Clinical Isolates from Cystic Fibrosis Patients
por: Papa, Rosanna, et al.
Publicado: (2021)

Impact of Pancreatitis-Associated Protein on Newborn Screening Outcomes and Detection of CFTR-Related Metabolic Syndrome (CRMS)/Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID): A Monocentric Prospective Pilot Experience
por: Bianchimani, Chiara, et al.
Publicado: (2022)

A Metagenomic and in Silico Functional Prediction of Gut Microbiota Profiles May Concur in Discovering New Cystic Fibrosis Patient-Targeted Probiotics
por: Vernocchi, Pamela, et al.
Publicado: (2017)

Liposomes Loaded With Phosphatidylinositol 5-Phosphate Improve the Antimicrobial Response to Pseudomonas aeruginosa in Impaired Macrophages From Cystic Fibrosis Patients and Limit Airway Inflammatory Response
por: Poerio, Noemi, et al.
Publicado: (2020)

Measuring Airway Surface Liquid Depth in Ex Vivo Mouse Airways by X-Ray Imaging for the Assessment of Cystic Fibrosis Airway Therapies
por: Morgan, Kaye S., et al.
Publicado: (2013)

Potential novel therapeutic strategies in cystic fibrosis: antimicrobial and anti-biofilm activity of natural and designed α-helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia
por: Pompilio, Arianna, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_0ag38e8i44og1ttuh1nnjvskkr